Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

RANKL causes lymph nodes to grow by making certain cells multiply.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Upadacitinib improved multiple immune-related conditions in one patient.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

ILC1-like cells may contribute to hair loss in alopecia areata.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

A parasite molecule can speed up skin healing and reduce scarring.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

RNase L suppresses regeneration in mammals.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

JAK inhibitors show promise in treating difficult skin diseases.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

miR-26b-5p in macrophage exosomes helps keloids grow.